Allarity Therapeutics, Inc.
NASDAQ: ALLR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Thomas H. Jensen
- Employees
- 6
- Headquarters
- Boston, United States
- IPO year
- 2021
- Market cap
- $20.7M
- Website
- https://www.allarity.com
Loading ALLR…
Loading profile data…Frequently asked questions about ALLR
What does Allarity Therapeutics, Inc. (ALLR) do?
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics. The company's portfolio of invest...
Where does ALLR trade?
Allarity Therapeutics, Inc. (ALLR) trades on the NASDAQ Global Market.
What sector is ALLR in?
Allarity Therapeutics, Inc. (ALLR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Allarity Therapeutics, Inc.?
Thomas H. Jensen is the chief executive officer of Allarity Therapeutics, Inc. (ALLR).
Where is Allarity Therapeutics, Inc. headquartered?
Allarity Therapeutics, Inc. is headquartered in United States.
Does ALLR pay a dividend?
Allarity Therapeutics, Inc. (ALLR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALLR go public?
Allarity Therapeutics, Inc. (ALLR) completed its initial public offering in 2021.